Τρίτη 23 Ιουλίου 2019


 
 
Single-dose neoadjuvant inhibition of phosphoinositide 3-kinase, mammalian target of rapamycin, and protein kinase B signaling in combination with thermal ablation may represent a candidate therapeutic strategy to prevent local recurrence of hepatocellular carcinoma after ablation.   
 
Danielle E. Jondal, Scott M. Thompson...David A. Woodrum
Image-Placeholder-225x150.png

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου